PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Clinical trial NCT06612814 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06612814
- Sponsor
- Zhimin Shao
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2027-10-30
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.